...
首页> 外文期刊>Journal of psychiatric research >Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
【24h】

Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.

机译:严重抑郁症患者的血清脑源性神经营养因子水平:抗抑郁药的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

This study tried to investigate the relationships between serum brain-derived neurotrophic factor (BDNF) protein levels and major depressive patients and discuss the effects of antidepressants on the serum BDNF protein levels. A total of 218 participants, including 111 patients with major depression (91 women) and 107 healthy controls (65 women), were recruited in this study. Serum BDNF protein levels were measured using an ELISA kit. Psychiatric diagnoses were made according to DSM-IV criteria. Severity of major depression was assessed by the 17-item Hamilton Depression Rating Scale. Using analysis of covariance with age adjustment, there were significantly low serum BDNF protein levels in depressive patients than healthy controls in women (F=7.530, p=0.007), but not in men. Additionally, changes in serum BDNF protein levels were significantly increased in 79 patients taking antidepressants during a period of 4 weeks (t=2.116, p=0.038), especially in 61 women (t=2.542, p=0.014). Age-adjusted ANCOVA revealed no significant differences in serum BDNF protein levels between 58 responders and 21 non-responders (F=0.008, P=0.928). In responders, there were significantly increased changes in serum BDNF protein levels in 44 women (t=2.501, p=0.016), but not in 14 men (t=-0.767, p=0.457). These analytical results suggest that low serum BDNF may play an important role in depressive women and antidepressant treatment significantly increase serum BDNF. However, further studies of larger populations are necessary to confirm these results and further elucidate the effects of different classes of antidepressants on serum BDNF protein levels.
机译:这项研究试图调查血清脑源性神经营养因子(BDNF)蛋白水平与重度抑郁症患者之间的关系,并探讨抗抑郁药对血清BDNF蛋白水平的影响。这项研究共招募了218名参与者,包括111名重度抑郁症患者(91名女性)和107名健康对照者(65名女性)。使用ELISA试剂盒测量血清BDNF蛋白水平。根据DSM-IV标准进行精神病学诊断。重度抑郁症的严重程度通过汉密尔顿抑郁评估量表(17个汉密尔顿抑郁量表)进行评估。使用年龄校正的协方差分析,在抑郁症患者中,女性的血清BDNF蛋白水平显着低于健康对照组(F = 7.530,p = 0.007),而男性则没有。此外,在4周内服用抗抑郁药的79例患者中,血清BDNF蛋白水平的变化显着增加(t = 2.116,p = 0.038),尤其是61名女性(t = 2.542,p = 0.014)。年龄调整后的ANCOVA显示58位应答者和21位非应答者之间的血清BDNF蛋白水平无显着差异(F = 0.008,P = 0.928)。在应答者中,有44名女性的血清BDNF蛋白水平变化显着增加(t = 2.501,p = 0.016),而14名男性则没有(t = -0.767,p = 0.457)。这些分析结果表明,低血清BDNF可能在抑郁症妇女中起重要作用,而抗抑郁药治疗会显着增加血清BDNF。但是,有必要对更大的人群进行进一步的研究以证实这些结果,并进一步阐明不同种类的抗抑郁药对血清BDNF蛋白水平的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号